Screener

Eligibility screening

Anti-GD2 ADC M3554 in Advanced Solid Tumors

Sponsored by EMD Serono Research & Development Institute, Inc.Study detailsClinicalTrials.gov

3 US sites in MA, NY, TX

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.